SEARCH

SEARCH BY CITATION

References

  • André, M., Chambrion, C., Charrin, S., Soave, S., Chaker, J., Boucheix, C., et al. (2009) In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface. J Proteomics 73: 93102.
  • Barreiro, O., Zamai, M., Yáñez-Mó, M., Tejera, E., López-Romero, P., Monk, P.N., et al. (2008) Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol 183: 527542.
  • Brazzoli, M., Bianchi, A., Filippini, S., Weiner, A., Zhu, Q., Pizza, M., and Crotta, S. (2008) CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol 82: 83168329.
  • Brimacombe, C.L., Grove, J., Meredith, L.W., Hu, K., Syder, A.J., Flores, M.V., et al. (2011) Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol 85: 596605.
  • Charrin, S., Le Naour, F., Oualid, M., Billard, M., Faure, G., Hanash, S.M., et al. (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276: 1432914337.
  • Charrin, S., Le Naour, F., Labas, V., Billard, M., Le Caer, J.-P., Emile, J.-F., et al. (2003a) EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J 373: 409421.
  • Charrin, S., Manié, S., Thiele, C., Billard, M., Gerlier, D., Boucheix, C., and Rubinstein, E. (2003b) A physical and functional link between cholesterol and tetraspanins. Eur J Immunol 33: 24792489.
  • Charrin, S., Le Naour, F., Silvie, O., Milhiet, P.-E., Boucheix, C., and Rubinstein, E. (2009a) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J 420: 133154.
  • Charrin, S., Yalaoui, S., Bartosch, B., Cocquerel, L., Franetich, J.-F., Boucheix, C., et al. (2009b) The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection. J Biol Chem 284: 3157231578.
  • Cukierman, L., Meertens, L., Bertaux, C., Kajumo, F., and Dragic, T. (2009) Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell–cell contacts. J Virol 83: 54775484.
  • Delgrange, D., Pillez, A., Castelain, S., Cocquerel, L., Rouille, Y., Dubuisson, J., et al. (2007) Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88: 24952503.
  • Dubuisson, J., Helle, F., and Cocquerel, L. (2008) Early steps of the hepatitis C virus life cycle. Cell Microbiol 10: 821827.
  • Espenel, C., Margeat, E., Dosset, P., Arduise, C., Le Grimellec, C., Royer, C.A., et al. (2008) Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web. J Cell Biol 182: 765776.
  • Evans, M.J., Hahn, T., Tscherne, D.M., Syder, A.J., Panis, M., Wölk, B., et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801805.
  • Farquhar, M.J., Harris, H.J., and McKeating, J.A. (2011) Hepatitis C virus entry and the tetraspanin CD81. Biochem Soc Trans 39: 532536.
  • Fofana, I., Krieger, S.E., Grunert, F., Glauben, S., Xiao, F., Fafi-Kremer, S., et al. (2010) Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology 139: 953964, 964.e1–.e4.
  • Gambin, Y., Lopez-Esparza, R., Reffay, M., Sierecki, E., Gov, N.S., Genest, M., et al. (2006) Lateral mobility of proteins in liquid membranes revisited. Proc Natl Acad Sci USA 103: 20982102.
  • Goueslain, L., Alsaleh, K., Horellou, P., Roingeard, P., Descamps, V., Duverlie, G., et al. (2010) Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J Virol 84: 773787.
  • Grove, J., and Marsh, M. (2011) The cell biology of receptor-mediated virus entry. J Cell Biol 195: 10711082.
  • Harris, H.J., Farquhar, M.J., Mee, C.J., Davis, C., Reynolds, G.M., Jennings, A., et al. (2008) CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 82: 50075020.
  • Harris, H.J., Davis, C., Mullins, J.G.L., Hu, K., Goodall, M., Farquhar, M.J., et al. (2010) Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 285: 2109221102.
  • Harris, H.J., Clerte, C., Farquhar, M.J., Goodall, M., Hu, K., Rassam, P., et al. (2012) Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell Microbiol doi: 10.1111/cmi.12047.
  • Jones, C.T., Catanese, M.T., Law, L.M.J., Khetani, S.R., Syder, A.J., Ploss, A., et al. (2010) Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol 28: 167171.
  • Kitadokoro, K., Bordo, D., Galli, G., Petracca, R., Falugi, F., Abrignani, S., et al. (2001) CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J 20: 1218.
  • Kovalenko, O.V., Yang, X., Kolesnikova, T.V., and Hemler, M.E. (2004) Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 377: 407417.
  • Krementsov, D.N., Rassam, P., Margeat, E., Roy, N.H., Schneider-Schaulies, J., Milhiet, P.-E., and Thali, M. (2010) HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic 11: 14011414.
  • Krieger, S.E., Zeisel, M.-B., Davis, C., Thumann, C., Harris, H.J., Schnober, E.K., et al. (2010) Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2–CD81–claudin-1 associations. Hepatology 51: 11441157.
  • Lindenbach, B.D., Evans, M.J., Syder, A.J., Wölk, B., Tellinghuisen, T.L., Liu, C.C., et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623626.
  • Lupberger, J., Zeisel, M.-B., Xiao, F., Thumann, C., Fofana, I., Zona, L., et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17: 589595.
  • Margeat, E., Kapanidis, A.N., Tinnefeld, P., Wang, Y., Mukhopadhyay, J., Ebright, R.H., and Weiss, S. (2006) Direct observation of abortive initiation and promoter escape within single immobilized transcription complexes. Biophys J 90: 14191431.
  • Michalet, X. (2010) Mean square displacement analysis of single-particle trajectories with localization error: Brownian motion in an isotropic medium. Phys Rev E Stat Nonlin Soft Matter Phys 82: 041914.
  • Montpellier, C., Tews, B.A., Poitrimole, J., Rocha-Perugini, V., D'Arienzo, V., Potel, J., et al. (2011) Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J Biol Chem 286: 1395413965.
  • Owen, D.M., Williamson, D., Rentero, C., and Gaus, K. (2009) Quantitative microscopy: protein dynamics and membrane organisation. Traffic 10: 962971.
  • Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., et al. (1998) Binding of hepatitis C virus to CD81. Science 282: 938941.
  • Ploss, A., Evans, M.J., Gaysinskaya, V.A., Panis, M., You, H., De Jong, Y.P., and Rice, C.M. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882886.
  • Rocha-Perugini, V., Montpellier, C., Delgrange, D., Wychowski, C., Helle, F., Pillez, A., et al. (2008) The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS ONE 3: e1866.
  • Rocha-Perugini, V., Lavie, M., Delgrange, D., Canton, J., Pillez, A., Potel, J., et al. (2009) The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiol 9: 111.
  • Russell, R.S., Meunier, J.-C., Takikawa, S., Faulk, K., Engle, R.E., Bukh, J., et al. (2008) Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci USA 105: 43704375.
  • Saffman, P.G., and Delbruck, M. (1975) Brownian motion in biological membranes. Proc Natl Acad Sci USA 72: 3111.
  • Sainz, B., Barretto, N., Martin, D.N., Hiraga, N., Imamura, M., Hussain, S., et al. (2012) Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18: 281285.
  • Sala-Valdés, M., Ursa, A., Charrin, S., Rubinstein, E., Hemler, M.E., Sánchez-Madrid, F., and Yáñez-Mó, M. (2006) EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J Biol Chem 281: 1966519675.
  • Sattentau, Q. (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815826.
  • Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R.M., Acali, S., Filocamo, G., et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21: 50175025.
  • Silvie, O., Charrin, S., Billard, M., Franetich, J.-F., Clark, K.L., van Gemert, G.-J., et al. (2006) Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites. J Cell Sci 119: 19922002.
  • Stipp, C.S., Kolesnikova, T.V., and Hemler, M.E. (2001) EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem 276: 4054540554.
  • Stipp, C.S., Kolesnikova, T.V., and Hemler, M.E. (2003) EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5. J Cell Biol 163: 11671177.
  • Timpe, J.M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M.J., Harris, H.J., et al. (2008) Hepatitis C virus cell–cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 1724.
  • Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791796.
  • Witteveldt, J., Evans, M.J., Bitzegeio, J., Koutsoudakis, G., Owsianka, A.M., Angus, A.G.N., et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 90: 4858.
  • Yang, X.H., Kovalenko, O.V., Kolesnikova, T.V., Andzelm, M.M., Rubinstein, E., Strominger, J.L., and Hemler, M.E. (2006) Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. J Biol Chem 281: 1297612985.
  • Zhang, X.A., Lane, W.S., Charrin, S., Rubinstein, E., and Liu, L. (2003) EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Cancer Res 63: 26652674.
  • Zhang, Y., Li, X., Becker, K.A., and Gulbins, E. (2009) Ceramide-enriched membrane domains – structure and function. Biochim Biophys Acta 1788: 178183.
  • Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102: 92949299.